Specimens should be inoculated onto enriched blood agar medium (containing vitamin K1 and hemin) and a selective medium (for Bacteroides spp.), such as laked sheep blood agar with kanamycin and vancomycin. The use of selective media along with nonselective one increases the recovery rate and can shorten the time to identification of organisms. Prereduced vitamin K1 enriched thioglycolate broth is used as a backup. However, this media alone should never be used as a substitute for a solid media. 3
Cultures should be placed immediately under anaerobic conditions and incubated for 48 hours or longer. Plates should then be examined for approximate number and types of colonies present. Each colony type should be isolated, tested for aerotolerance and identified.
An additional period of 36–48 hours is generally required to identify completely the anaerobic bacteria to a species or genus level using biochemical tests. Kits containing these biochemical tests are commercially available. These are good with fast growing anaerobes (i.e. Bacteroides fragilis and Clostridium perfringens). Rapid enzymatic tests are also available. This panel test allows identification after only 4 hours incubation. Other rapid tests are the direct fluorescent microscopy and gas liquid chromatography. Direct cellular fatty acid analysis using gas liquid chromatography with capillary column can also be useful. Nucleic acid probes and polymerase chain reaction methods are developed for rapid identification of anaerobes.
Most clinical microbiology laboratories are able to identify the major anaerobic bacteria. Peptostreptococci are generally not speciated because they are generally susceptible to commonly used antimicrobials. Clostridium spp. can be identified by the presence of spores and their ability to survive 30 minutes exposure to ethanol or heating to 80°C for 10 minutes. Nonspore-forming Gram-positive bacilli can be speciated by gas liquid chromatography and biochemical tests. Propionibacterium spp., which are often a contaminant, can be separated from other nonspore-forming Gram-positive bacilli by a catalyze test and indole reaction. B. fragilis group grows on 20% bile and is generally catalase positive.
Pigmented Prevotella and Porphyromonas spp. produce black or brown pigment within a week when growing on rabbit blood agar medium. Fusobacterium spp. have distinct morphology on Gram stain and, in contrast to Bacteroides spp., are susceptible to kanamycin.
Identification of an anaerobe to a species level is often cumbersome, expensive and time-consuming, taking up to 72 hours. Identification is most helpful in selecting an antibiotic against a species that has predictable antibiotic susceptibility. Occasionally, species identification of an organism will provide the diagnosis, as with Clostridium difficile in colitis or Clostridium botulinum in botulism. Identifying B. fragilis group, which often cause bacteremia and septic complications, has significant prognostic value. However, because most anaerobes are endogenous, there are rarely epidemiologic reasons to perform complete identification.
The antimicrobial susceptibility of anaerobes has become less predictable. Resistance to several antimicrobials, especially by anaerobic Gram-negative bacilli (AGNB) and Fusobacterium spp., has increased.4 It is important to test susceptibility of anaerobes recovered from sterile body sites, those with particular epidemiologic or prognostic significance (e.g. C. difficile), or those that are clinically important and have variable susceptibilities.
Screening of AGNB isolates (particularly Prevotella, Bacteroides and Fusobacterium spp.) for beta-lactamase activity is helpful. However, occasional resistance is through other mechanisms.
Routine susceptibility testing is extremely time-consuming and often unnecessary. It should be limited to isolates from blood, bone, central nervous system and serious infections, as well as to those recovered in pure culture. Antibiotics tested should include penicillin, a broad-spectrum penicillin, a penicillin plus a beta-lactamase inhibitor, clindamycin, chloramphenicol, a second-generation cephalosporin (e.g. cefoxitin), metronidazole and a carbapenem . 5
The method recommended by the National Committee for Clinical Laboratory Standards (NCCLS) includes agar dilution testing, microbroth and macrobroth dilution.4 Newer methods include the E-test and the spiral gradient end-point system.
E-test susceptibility testing method for anaerobes
1. Summanen P, Baron EJ, Ciron DM, et al. Wadsworth anaerobic bacteriology manual. 6th ed. Belmont, CA: Star Publishing; 2002.
2. Finegold SM. Anaerobic bacteria in human disease. Orlando, FL: Academic Press Inc; 1977.
3. Brook. Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J Clin Microbiol. 1988 ;26:1181-8.
4. National Committee for Clinical Laboratory Standards Working Group on Susceptibility Testing of Anaerobic Bacteria.. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 4th ed.; approved standard. NCCLS document M11-A4. Vol. 13, No. 26. Villanova, PA, 1997.
5. Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
Clin Infect Dis. 2002 ;35(Suppl 1):S126-34.
Table 1: Methods for collection of specimen for anaerobic bacteria
Infection site
|
Methods
|
Abscess or body cavity
|
Aspiration by syringe and needle
|
|
Incised abscesses - syringe, or swab (less desirable); specimen obtained during surgery after cleansing the skin
|
Tissue or bone
|
Surgical specimen using tissue biopsy or curette
|
Sinuses or mucus surface abscesses
|
Aspiration after decontamination or surgical specimen
|
Ear
|
Aspiration after decontamination of ear canal and membrane; in perforation: cleanse ear canal and aspirate through perforation
|
Pulmonary
|
Transtracheal aspiration, lung puncture, bronchoscopic aspirate*
|
Pleural
|
Thoracentesis
|
Urinary tract
|
Suprapubic bladder aspiration
|
Female genital tract
|
Culdocentesis following decontamination, surgical specimen
Transabdominal needle aspirate of uterus
intrauterine brush*
|
*using double lumen catheter and quantitative culture.
Table 2: SPECIMENS THAT SHOULD NOT BE CULTURED FOR ANAEROBES
1) Feces or rectal swabs
2) Throat or nasopharyngeal swabs
3) Sputum or bronchoscopic specimens
4) Routine or catherized urine
5) Vaginal or cervical swabs
6) Material from superficial wound or abscesses not collected properly to exclude surface
contaminations
7) Material from abdominal wounds obviously contaminated with feces, such as an open fistula
Table 3: SPECIMENS APPROPRIATE FOR ANAEROBIC CULTURE
1) All normally sterile body fluids other than urine, such as blood, pleural, and joint fluids
2) Urine obtained by suprapubic bladder aspiration
3) Percutaneous transtracheal aspiration, direct lung puncture, or double lumen catheter bronchial
brushing and bronchoalveolar lavage (both cultured quantitavely).
4) Culdocentesis fluid obtained after decontamination of the vagina
5) Material obtained from closed abscesses
6) Material obtained from sinus tracts or draining wounds
Table 4. Bacteriological finding suggestive of anaerobic infection.
1. Inability to grow in aerobic cultures, organisms seen on Gram stain of the original material
2. Typical morphology for anaerobes on Gram stain
3. Anaerobic growth on proper media containing antibiotic-suppressing aerobes
4. No growth or routine bacterial culture (“sterile-pus”)
5. Growth in anaerobic zone of fluid or agar media
6. Growth anaerobically on media containing puromomycin, Kanamycin, neomycin or vancomycin.
7. Gas, foul-smelling odor in specimen or bacterial culture
8. Characteristic colonies on anaerobic plates
9. Young colonies of Pigmented Prevotella and Porphyromonas may fluoresce red under ultraviolet light, and older colonies produce a typical dark pigment
10. Characteristic colonies on agar plates under anaerobic conditions (e.g. Clostridium perfringens, Fusobacterium nucleatum).